Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: A randomised, double-blind, BCG-controlled trial in Sudan

Lancet

Volumn 356, Issue 9241, 2000, Pages 1565-1569

  Khalil, E A G ^a,e   El Hassan, A M ^a   Zijlstra, E E ^a   Mukhtar, M M ^a   Ghalib, H W ^b   Musa, Breyma ^a   Ibrahim, M E ^a   Kamil, Areeg A ^a   Elsheikh, M ^a   Babiker, A ^c   Modabber, F ^d  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

LEISHMANIA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; INJECTION SITE; LEISHMANIA; LEISHMANIASIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROMASTIGOTE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SUDAN;

EID: 0034605714     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03128-7     Document Type: Article

References (19)

1. Early phases of an outbreak of kala-azar in the southern Fung
2. Epidemic visceral leishmaniasis in southern Sudan
3. Outbreak of kala-azar in Sudan
4. Kala-azar in displaced people from southern Sudan: Epidemiological, clinical and therapeutic findings
5. Kala-azar in Western Upper Nile in southern Sudan and its spread to a nomadic tribe from the north
6. Endemic kala-azar in eastern Sudan: A longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis
7. Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: Management of those who do not respond
8. Resistance against L donovani induced with an aluminium hydroxide vaccine
9. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis
10. Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L major plus BCG
11. Double-blind randomized controlled vaccine trial of a single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran
12. A randomized, double-blind, controlled trial of a killed L major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran
13. Measurement of delayed skin test responses
14. A simple and economical direct agglutination test for sero-diagnosis and sero-epidemiological studies of visceral leishmaniasis
15. Antigenic cross-reactivity between Mycobacterium bovis (BCG) and Leishmania donovani
16. The effect of BCG on experimental cutaneous leishmaniasis in mice
17. Controlled field trials of a vaccine against new world cutaneous leishmaniasis
18. Immune response in health volunteers vaccinated with killed leishamanial promastigotes plus BCG; I, skin test reactivity, T-cell proliferation and interferon-γ production
19. Induction and modulation of the immune response to Leishmania by Montenegro's skin test